disease-modifying antirheumatic drugs
Rheumatologists now seem to accept that early treatment of patients with       rheumatoid arthritis with disease-modifying antirheumatic drugs is required if       erosions are to be prevented.
Rheumatologists now seem to accept that early  @PREDICAT$  of  @OBJECT$  with       rheumatoid arthritis with  @SUBJECT$  is required if       erosions are to be prevented.